USEFULNESS OF SIMPLE SHIELDING TECHNIQUE USING MULTILEAF COLLIMATOR IN BREAST RADIATION THERAPY |
Lee, Kyu Chan
(Department of Radiation Oncology, Gil Medical Center, School of Medicine, Gachon University)
Lee, Seok Ho (Department of Radiation Oncology, Gil Medical Center, School of Medicine, Gachon University) Lee, Seung Heon (Department of Radiation Oncology, Gil Medical Center, School of Medicine, Gachon University) Sung, Kihoon (Department of Radiation Oncology, Gil Medical Center, School of Medicine, Gachon University) Ahn, So Hyun (Department of Radiation Oncology, Gil Medical Center, School of Medicine, Gachon University) Choi, Jinho (Department of Radiation Oncology, Gil Medical Center, School of Medicine, Gachon University) Dong, Kap Sang (Department of Radiation Oncology, Gil Medical Center, School of Medicine, Gachon University) Kim, Hyo Jin (Department of Radiation Oncology, Gil Medical Center, School of Medicine, Gachon University) Chun, Yong Seon (Department of Surgery, Gil Medical Center, School of Medicine, Gachon University) Park, Heung Kyu (Department of Surgery, Gil Medical Center, School of Medicine, Gachon University) |
1 | Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-1716. DOI ScienceOn |
2 | Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New. Engl. J. Med. 2002;347(16):1227-1232. DOI ScienceOn |
3 | Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6(8):557-565. DOI ScienceOn |
4 | Clarke M, Collins R, Darby S, et al. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366(9503):2087-2106. DOI ScienceOn |
5 | Darby SC, Ewertz M, McGale P, et al. Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. New. Engl. J. Med. 2013;368(11):987-998. DOI ScienceOn |
6 | Taylor CW, Povall JM, McGale P, et al. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int. J. Radiat. Oncol. Biol. Phys. 2008;72(2):501-507 DOI ScienceOn |
7 | Aznar MC, Korreman S-S, Pedersen AN, et al. Evaluation of dose to cardiac structures during breast irradiation. Br. J. Radiol. 2011;84(1004): 743-746. DOI ScienceOn |
8 | Carr ZA, Land CE, Kleinerman RA, et al. Coronary heart disease after radiotherapy for peptic ulcer disease. Int. J. Radiat. Oncol. Biol. Phys. 2005;61(3):842-850. DOI ScienceOn |
9 | Shimizu Y, Kodama K, Nishi N, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ. 2010;340:5349. DOI ScienceOn |
10 | Taylor CW, Povall JM, McGale P, et al. Cardiac Dosefrom tangential breast cancer radiotherapy in the year 2006. Int. J. Radiat. Oncol. Biol. Phys. 2008;72(2):501-507. DOI ScienceOn |
11 | Bartlett FR, Yarnold JR, Donovan EM, Evans PM, Locke I, Kirby AM. Multileaf collimation cardiac shielding in breast radiotherapy: Cardiac doses are reduced, but at what cost? Clin. Oncol. 2013;25(12):690-696. DOI ScienceOn |
12 | Feng M, Moran JM, Koelling T, et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 2011;79(1):10-18. DOI ScienceOn |
13 | Bartelink H, Garavaglia G, Johansson KA, et al. Quality assurance in conservative treatment of early breast cancer. Report on a consensus meeting of the EORTC Radiotherapy and Breast Cancer Cooperative Groups and the EUSOMA (European Society of Mastology). Radiother. Oncol. 1991;22(4):323-326. DOI ScienceOn |
14 | ICRU. Prescribing, recording and reporting photon beam therapy. ICRU Report 62. 1999. |
15 | Allen AM, Czerminska M, Jänne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int. J. Radiat. Oncol. Biol. Phys. 2006;65(3):640-645. DOI ScienceOn |
16 | Darby SC, McGale P, Taylor CW, et al. Longterm mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6(8):557-565. DOI ScienceOn |
17 | Stevens CW, Forster KM, Smythe WR, et al. Radiotherapy for mesothelioma. Hematol. Oncol. Clin. North Am. 2005; 19(6):1099-1115. DOI ScienceOn |
18 | Yorke ED, Jackson A, Rosenzweig KE, et al. Correlation of dosimetric factors and radiation pneumonitis for non-small- cell lung cancer patients in a recently completed dose escalation study. Int. J. Radiat. Oncol. Biol. Phys. 2005; 63(3):672-682. DOI ScienceOn |
19 | Zhang X-J, Sun J-G, Sun J, et al. Prediction of radiation pneumonitis in lung cancer patients: a systematic review. J. Cancer Res. Clin. Oncol. 2012;138(12):2103-2116 DOI ScienceOn |
20 | Cheng JCH, Wu JK, Huang CM, et al. Radiationinduced liver disease after radiotherapy for hepatocellular carcinoma: Clinical manifestation and dosimetric description. Radiother. Oncol. 2002; 63(1):41-45. DOI ScienceOn |
21 | Iavarone M, Colombo M. HBV infection and hepatocellular carcinoma. Clin. Liver Dis. 2013; 17(3):375-397. DOI ScienceOn |
22 | McGale P, Darby SC, Hall P, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother. Oncol. 2011;100(2):167-175. DOI ScienceOn |
23 | Fowble B, Solin LJ, Schultz DJ, et al. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int. J. Radiat. Oncol. Biol. Phys. 1990;19(4):833-842. DOI ScienceOn |
24 | Kontos M, Allen DS, Agbaje OF, et al. Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen. Eur. J. Surg. Oncol. 2011;37(12):1051-1058. DOI ScienceOn |
25 | Price P, Walsh G, McKinna AJ, et al. Patterns of breast relapse after local excision +/- radiotherapy for early stage breast cancer. Radiother. Oncol. 1988;13(1):53-60. DOI ScienceOn |
26 | Horst KC, Smitt MC, Goffinet DR, et al. Predictors of local recurrence after breast-conservation therapy. Clin. Breast Cancer. 2005;5(6):425-438. DOI ScienceOn |
27 | Jones HA, Antonini N, Hart AA, et al. Impact of pathological characteristics on local relapse after breast-conserving therapy: A subgroup analysis of the EORTC boost versus no boost trial. J. Clin. Oncol. 2009;27(30):4939-47. DOI ScienceOn |